Entest Group Inc

[JokersWild12]

The tCellvax IND submitted by Regen 3/23/16 mentions that studies in animals show that the immune response is as effective as with humans.

Matter of time for ENTB. BTW this method was first announced at ENTB before seen for human indications for treatment at Regen.

From 3/23/16 PR:

tCellVax is comprised of cells extracted from the patient's own circulating immune cells and processed using a proprietary method so as to activate these immune cells in such a way that they can attack cancer cells. Studies in animal and human immune cells by Regen and other groups have shown the cells in tCellVax are highly active and secrete the same cytokines that immune cells known to kill cancer cells do. Thus, we are optimistic this treatment will be useful in patients with cancer.

GL